Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00155233
Status:
UNKNOWN
Last Update Posted:
2005-11-23
First Post:
2005-09-08
Brief Title:
Interaction Between Nalbuphine and Morphine in PCA
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Interaction Between Nalbuphine and Morphine in Postoperative PCA for Gynecologic Patients
Status:
UNKNOWN
Status Verified Date:
2005-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist
2 This study was designed to investigate the interaction between nalbuphine and morphine
2 This study was designed to investigate the interaction between nalbuphine and morphine
Detailed Description:
1 Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist
2 This study was designed to investigate the interaction between nalbuphine and morphine
3 The analgesic effect and opioid-related side effects will be investigated
2 This study was designed to investigate the interaction between nalbuphine and morphine
3 The analgesic effect and opioid-related side effects will be investigated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None